<DOC>
	<DOCNO>NCT01186601</DOCNO>
	<brief_summary>The study conduct open label , single-dose , explorative study patient histologically proven cancer , preferably , tumor positive lesion previously perform nuclear medicine image examination . The investigational drug give single administration dose &lt; /= 0.1 mg BAY94-9392 ( 300 MBq , +/- 10 % ) . The total duration study patient approximately 8 day .</brief_summary>
	<brief_title>Exploration Tumor Accumulation BAY94-9392 Patients With Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Males/females &gt; /= 18 year Patients diagnosis primary prostate cancer ( biopsy proven ) schedule radical prostatectomy patient prostate tumor recurrence ( Patients advance tumor disease high likelihood display lymph node metastasis preferably include . ) ECOG ( Eastern Cooperative Oncology Group ) performance status 02 , determine within one week prior treatment BAY949392 Patient [ 18F ] fluorodeoxyglucose ( FDG ) PET/CT detection , stag , restaging , therapy response assessment still show tumor mass high certainty cancer melanoma , colorectal cancer , head &amp; neck cancer FDGPET/CT use clinical routine , primary cancer disease histologically confirm . In case recurrent disease confirmation primary tumor sufficient No clinically relevant deviation renal function determine Cockcroft Gault method use serum creatinine screening . Concurrent severe and/or uncontrolled and/or unstable medical disease cancer inflammation ( e.g . poorly control diabetes , congestive heart failure , myocardial infarction within 12 month prior plan injection BAY949392 , unstable uncontrolled hypertension , chronic renal hepatic disease , severe pulmonary disease ) could compromise participation study Known sensitivity study drug component preparation Previous treatment BAY949392 study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Prostatic Neoplasms</keyword>
	<keyword>Colorectal Neoplasms</keyword>
	<keyword>Head Neck Neoplasms</keyword>
	<keyword>Melanoma</keyword>
	<keyword>Neoplasm Metastasis</keyword>
</DOC>